RemeGen Co., Ltd. (9995.HK)

HKD 15.52

(-0.26%)

Operating Expenses Summary of RemeGen Co., Ltd.

RemeGen Co., Ltd.'s latest annual operating expenses in 2023 was 2.32 Billion CNY , up 49.84% from previous year.
RemeGen Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 741.53 Million CNY , up 24.51% from previous quarter.
RemeGen Co., Ltd. reported a annual operating expenses of 1.55 Billion CNY in annual operating expenses 2022, up 47.29% from previous year.
RemeGen Co., Ltd. reported a annual operating expenses of 1.05 Billion CNY in annual operating expenses 2021, up 65.35% from previous year.
RemeGen Co., Ltd. reported a quarterly operating expenses of 595.55 Million CNY for 2024 Q1, down -17.26% from previous quarter.
RemeGen Co., Ltd. reported a quarterly operating expenses of 587.28 Million CNY for 2023 Q3, up 5.31% from previous quarter.

Annual Operating Expenses Chart of RemeGen Co., Ltd. (2023 - 2018)

Historical Annual Operating Expenses of RemeGen Co., Ltd. (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	2.32 Billion CNY	49.84%
2022	1.55 Billion CNY	47.29%
2021	1.05 Billion CNY	65.35%
2020	637.24 Million CNY	63.92%
2019	388.74 Million CNY	66.23%
2018	233.85 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	741.53 Million CNY	24.51%
2024 Q1	595.55 Million CNY	-17.26%
2023 Q3	587.28 Million CNY	5.31%
2023 FY	2.32 Billion CNY	49.84%
2023 Q4	719.8 Million CNY	22.57%
2023 Q2	557.67 Million CNY	17.58%
2023 Q1	474.3 Million CNY	6.22%
2022 Q3	398.85 Million CNY	13.32%
2022 Q1	348.55 Million CNY	17.63%
2022 Q2	351.97 Million CNY	0.98%
2022 FY	1.55 Billion CNY	47.29%
2022 Q4	446.51 Million CNY	11.95%
2021 Q3	339.69 Million CNY	19.61%
2021 Q1	198.48 Million CNY	-8.96%
2021 FY	1.05 Billion CNY	65.35%
2021 Q2	284.01 Million CNY	43.09%
2021 Q4	296.31 Million CNY	-12.77%
2020 Q3	218.01 Million CNY	51.78%
2020 Q4	218.01 Million CNY	0.0%
2020 Q2	143.64 Million CNY	58.09%
2020 Q1	90.86 Million CNY	-14.2%
2020 FY	637.24 Million CNY	63.92%
2019 Q1	75.33 Million CNY	33419.02%
2019 FY	388.74 Million CNY	66.23%
2019 Q4	105.89 Million CNY	0.0%
2019 Q3	105.89 Million CNY	6.41%
2019 Q2	99.51 Million CNY	32.1%
2018 Q4	224.75 Thousand CNY	0.0%
2018 Q2	379.5 Thousand CNY	0.0%
2018 Q1	379.5 Thousand CNY	0.0%
2018 FY	233.85 Million CNY	0.0%
2017 Q4	379.5 Thousand CNY	0.0%

Peer Operating Expenses Comparison of RemeGen Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-615.379%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	-214.552%